Balance is key to weathering market fluctuations while capturing growth potential over full market cycles.
We maintain a well-balanced mix of equities, fixed income, and cash instruments to manage downside risk while participating in long-term market upside.
We target market leaders with strong organic growth rates, scalable business models, robust free cash flows, and difficult-to-replicate products or services.
Our buy/sell discipline mandates purchasing high-quality businesses during favorable market conditions or valuation pullbacks, and selling when fundamentals deteriorate.
Capturing opportunities across the entire spectrum of high-performing public equities.
While large-cap market leaders form the foundation of our equity exposure, we continuously identify high-conviction small- and mid-cap companies with outstanding growth trajectories.
We blend core individual stock holdings and proprietary mutual funds with specialized complementary assets to fulfill unique tax, income, or liquidity requirements.
Modeled with the precision of a clinical development pipeline to evaluate every potential stock investment.
Quantitative and qualitative screening across broad global sectors to isolate companies with clean balance sheets, strong return on equity, and secular tailwinds.
In-depth valuation modeling, financial statement scrutiny, executive assessment, and opportunity-cost comparison against existing portfolio holdings.
Final review by portfolio managers to establish exact position sizing, risk thresholds, and buy-target ranges aligned with client mandates.
Talk with our Madison-based research and portfolio management team today.
Contact Our Advisors